The Design for a Phase II, Randomized, Multicenter Study of Ctdna-Guided Treatment with Furmonertinib Combined Therapy or Furmonertinib Alone for Untreated Advanced EGFR Mutant Non-Small Cell Lung Cancer Patients: the FOCUS-C Study
Clinical Lung Cancer（2024）
Key words
Clinical trial,NSCLC,Circulating tumor cell DNA,Clearance,TKI
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined